Santa Cruz, CA, United States of America

Gwen Tatsuno

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: University of California. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gwen Tatsuno. Retrieved from https://idiyas.com/inventor/gwen-tatsuno-92w49rox

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gwen Tatsuno: Innovator in HIV-1 Research

Introduction

Gwen Tatsuno is a prominent inventor based in Santa Cruz, CA (US). She has made significant contributions to the field of HIV-1 research, holding 2 patents that focus on innovative approaches to combat the virus. Her work is crucial in the ongoing fight against HIV/AIDS.

Latest Patents

Tatsuno's latest patents include the development of V1/V2 fragments of an HIV-1 envelope glycoprotein. These HIV-1 envelope proteins and fragments possess naturally occurring and novel engineered epitopes that can elicit and are recognized by broadly neutralizing antibodies. Another notable patent is for HIV-1 GP 120 V1/V2 antigens and their immunological uses, which also focus on the same innovative approach to stimulate immune responses against HIV.

Career Highlights

Gwen Tatsuno is affiliated with the University of California, where she conducts her research. Her work has been instrumental in advancing our understanding of HIV-1 and developing potential therapeutic strategies.

Collaborations

Some of her notable coworkers include Javier Morales and Bin Yu, who contribute to her research efforts and help drive innovation in the field.

Conclusion

Gwen Tatsuno's contributions to HIV-1 research through her patents and collaborations highlight her role as a key innovator in the scientific community. Her work continues to pave the way for advancements in HIV treatment and prevention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…